PK and Safety of Beclomethasone Dipropionate via Breath-Actuated Inhaler and Metered-Dose Inhaler

Study Title
A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults
Teva Identifier
BDB-AS-101
ClinicalTrials.gov Identifier
NCT02030457
Study Status
Completed
Trial Condition(s)
Pharmacokinetics
Interventions
Drug: Beclomethasone dipropionate BAI | Drug: Beclomethasone dipropionate MDI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age group
Adult
Age Range
18 Years to 45 Years
Trial Duration
12/01/2013 - 06/01/2014
Phase
Phase 1

Study Type

Interventional